Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.3M Sell
10,957
-772
-7% -$89.1K 0.02% 413
2026
Q1
$1.4M Sell
11,729
-436
-4% -$57.2K 0.03% 346
2025
Q4
$1.66M Buy
12,165
+112
+0.9% +$16.1K 0.03% 301
2025
Q3
$1.78M Sell
12,053
-1,588
-12% -$220K 0.04% 274
2025
Q2
$1.76M Buy
13,641
+176
+1% +$21.3K 0.04% 256
2025
Q1
$1.61M Sell
13,465
-3
-0% -$372 0.04% 243
2024
Q4
$1.56M Buy
13,468
+795
+6% +$101K 0.04% 278
2024
Q3
$1.71M Buy
12,673
+1,911
+18% +$256K 0.04% 256
2024
Q2
$1.46M Sell
10,762
-933
-8% -$127K 0.04% 252
2024
Q1
$1.51M Sell
11,695
-4,501
-28% -$544K 0.05% 238
2023
Q4
$1.85M Buy
16,196
+1,164
+8% +$116K 0.06% 183
2023
Q3
$1.37M Buy
15,032
+4,357
+41% +$449K 0.05% 202
2023
Q2
$1.2M Buy
10,675
+3,643
+52% +$385K 0.04% 228
2023
Q1
$736K Buy
7,032
+2,836
+68% +$296K 0.03% 336
2022
Q4
$464K Buy
4,196
+96
+2% +$10.1K 0.02% 447
2022
Q3
$358K Buy
+4,100
New +$373K 0.02% 489

Other funds holding XYL

Diversified Trust's XYL Position: Q2 2026 in Review

Diversified Trust reduced its Xylem (XYL) stake by 6.6% in Q2 2026, selling an estimated $89.1K and leaving 10,957 shares worth $1.3M. The position accounts for 0.02% of the portfolio, ranked #413.

Diversified Trust first reported a position in XYL in Q3 2022 and has held it in 16 quarters since. The position peaked at $1.85M in Q4 2023. 1,093 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Diversified Trust held 10,957 shares of Xylem worth $1.3M as of Q2 2026.
  • Diversified Trust sold 772 Xylem shares in Q2 2026, an estimated $89.1K.
  • Xylem made up 0.02% of Diversified Trust's portfolio in Q2 2026, its #413 holding.
  • Diversified Trust first reported a position in Xylem in Q3 2022 and has held it in 16 quarters since.
  • Diversified Trust's Xylem position peaked at $1.85M in Q4 2023.
  • 1,093 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.